mirror of
https://github.com/msberends/AMR.git
synced 2025-07-08 23:21:56 +02:00
(v1.7.0) unit tests
This commit is contained in:
@ -339,17 +339,17 @@ Unique: 2</p>
|
||||
<div class="sourceCode" id="cb8"><pre class="downlit sourceCode r">
|
||||
<code class="sourceCode R"><span class="fu"><a href="https://rdrr.io/r/utils/head.html">head</a></span><span class="op">(</span><span class="va">my_TB_data</span><span class="op">)</span>
|
||||
<span class="co"># rifampicin isoniazid gatifloxacin ethambutol pyrazinamide moxifloxacin</span>
|
||||
<span class="co"># 1 R I I I S R</span>
|
||||
<span class="co"># 2 R R S R S S</span>
|
||||
<span class="co"># 3 I R S S S R</span>
|
||||
<span class="co"># 4 I I I R S I</span>
|
||||
<span class="co"># 5 I R R I R S</span>
|
||||
<span class="co"># 6 R R R R I S</span>
|
||||
<span class="co"># 1 I I I I S S</span>
|
||||
<span class="co"># 2 R I S I I I</span>
|
||||
<span class="co"># 3 S R R R R I</span>
|
||||
<span class="co"># 4 S R S S R S</span>
|
||||
<span class="co"># 5 R S I R S R</span>
|
||||
<span class="co"># 6 R R R R I I</span>
|
||||
<span class="co"># kanamycin</span>
|
||||
<span class="co"># 1 S</span>
|
||||
<span class="co"># 1 I</span>
|
||||
<span class="co"># 2 I</span>
|
||||
<span class="co"># 3 R</span>
|
||||
<span class="co"># 4 S</span>
|
||||
<span class="co"># 3 S</span>
|
||||
<span class="co"># 4 R</span>
|
||||
<span class="co"># 5 I</span>
|
||||
<span class="co"># 6 I</span></code></pre></div>
|
||||
<p>We can now add the interpretation of MDR-TB to our data set. You can use:</p>
|
||||
@ -367,7 +367,7 @@ Unique: 2</p>
|
||||
<p>Class: factor > ordered (numeric)<br>
|
||||
Length: 5,000<br>
|
||||
Levels: 5: Negative < Mono-resistant < Poly-resistant < Multi-drug-resistant <…<br>
|
||||
Available: 5,000 (100%, NA: 0 = 0%)<br>
|
||||
Available: 5,000 (100.0%, NA: 0 = 0.0%)<br>
|
||||
Unique: 5</p>
|
||||
<table class="table">
|
||||
<thead><tr class="header">
|
||||
@ -382,40 +382,40 @@ Unique: 5</p>
|
||||
<tr class="odd">
|
||||
<td align="left">1</td>
|
||||
<td align="left">Mono-resistant</td>
|
||||
<td align="right">3200</td>
|
||||
<td align="right">64.00%</td>
|
||||
<td align="right">3200</td>
|
||||
<td align="right">64.00%</td>
|
||||
<td align="right">3271</td>
|
||||
<td align="right">65.42%</td>
|
||||
<td align="right">3271</td>
|
||||
<td align="right">65.42%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">2</td>
|
||||
<td align="left">Negative</td>
|
||||
<td align="right">1014</td>
|
||||
<td align="right">20.28%</td>
|
||||
<td align="right">4214</td>
|
||||
<td align="right">84.28%</td>
|
||||
<td align="right">949</td>
|
||||
<td align="right">18.98%</td>
|
||||
<td align="right">4220</td>
|
||||
<td align="right">84.40%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">3</td>
|
||||
<td align="left">Multi-drug-resistant</td>
|
||||
<td align="right">455</td>
|
||||
<td align="right">9.10%</td>
|
||||
<td align="right">449</td>
|
||||
<td align="right">8.98%</td>
|
||||
<td align="right">4669</td>
|
||||
<td align="right">93.38%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">4</td>
|
||||
<td align="left">Poly-resistant</td>
|
||||
<td align="right">252</td>
|
||||
<td align="right">5.04%</td>
|
||||
<td align="right">4921</td>
|
||||
<td align="right">98.42%</td>
|
||||
<td align="right">240</td>
|
||||
<td align="right">4.80%</td>
|
||||
<td align="right">4909</td>
|
||||
<td align="right">98.18%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">5</td>
|
||||
<td align="left">Extensively drug-resistant</td>
|
||||
<td align="right">79</td>
|
||||
<td align="right">1.58%</td>
|
||||
<td align="right">91</td>
|
||||
<td align="right">1.82%</td>
|
||||
<td align="right">5000</td>
|
||||
<td align="right">100.00%</td>
|
||||
</tr>
|
||||
|
Reference in New Issue
Block a user